Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)

NCT02538341 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT02538341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02538341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2016
Completion date
December 31, 2020
Enrollment
617 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, arthritis, crohn's disease, enteropathic arthritis, inflammatory arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis